National Health Investors (NHI) reported a strong first quarter in 2023, with net income attributable to common stockholders at $0.79 per diluted share, up from $0.18 in the prior year. NAREIT FFO per diluted share increased to $1.16 from $1.05, and Normalized FFO per diluted share was $1.11, slightly up from $1.10. The company is revising its 2023 annual guidance upwards for Normalized FFO per share and Normalized FAD.
Net income attributable to common stockholders per diluted common share increased to $0.79, compared to $0.18 in the same period last year.
NAREIT FFO per diluted common share rose to $1.16, up from $1.05 in the prior year.
Normalized FFO per diluted common share saw a slight increase to $1.11, compared to $1.10 in the same period last year.
The company is revising its 2023 annual guidance range for Normalized FFO per share to $4.37 - $4.42 and Normalized FAD to a range of $186.3 million - $188.9 million.
NHI is revising its 2023 annual guidance range for Normalized FFO per share to $4.37 - $4.42 from $4.24 - $4.30 and is revising Normalized FAD to a range of $186.3 million - $188.9 million from $185.3 million - $187.9 million.